RedCarpetLife
1973
In the world today
Masateru Uno & family

Masateru Uno & family

M. family
0.1% | + $2.08M
$2.08 B ₹ 18,955 Cr
Real Time Net Worth #1973 Ranking as of 21 Feb 2026 By Forbes

More on Masateru Uno & family

Gender

Male

Age

79Y

Country

Japan

Born On

January, 1947

Deceased

No

Relationship Status

Unknown

Children

1

Education

Unknown

Designation Info :

Self-Made

Yes

Entrepreneur Type

Self-Made (Retail)

Primary Organization

Cosmos Pharmaceutical

Titles

Founder & Chairman

Sources of Wealth

Drugstores

Industry

Fashion-Retail, Healthcare

About Masateru Uno & family


M asateru Uno is the founder and chairman of Cosmos Pharmaceutical, a highly successful discount drugstore chain based in Fukuoka, Japan. He established the company in 1983 and pioneered a business model focused on large-format stores in suburban and rural locations, offering a wide range of products from pharmaceuticals and cosmetics to food and daily necessities at competitive prices. This strategy allowed Cosmos to dominate markets in Kyushu and expand rapidly across western Japan.

Uno's approach of owning the land for his stores to reduce costs and maintain high profitability has been a key driver of the company's success. Cosmos Pharmaceutical is listed on the Tokyo Stock Exchange and operates over 1,500 stores. Masateru Uno shares his fortune with his family, and his son, Yukitaka Uno, is actively involved in the business as a director, ensuring the continuity of the family's leadership in the Japanese retail sector.

Advertisement

Quick Reads


Early Life and Background


Masateru Uno is a Japanese businessman, the Founder and Chairman of Cosmos Pharmaceutical (TYO: 3349), a major retail chain that operates over 1,500 drugstores in Japan. The company sells medicines, cosmetics, food, and beverages.

He founded the company in 1997. His son, Yukitaka, is a director of the company and heads product development.

  • Core Company: Cosmos Pharmaceutical (TYO: 3349), a major drugstore chain.
  • Founding: Founded in 1997.
  • Scale: Operates over 1,500 drugstores in Japan.

Career Journey of Masateru Uno & family


Masateru Uno's career is defined by the successful expansion of Cosmos Pharmaceutical into one of Japan's largest drugstore chains. By rapidly scaling to over 1,500 locations, the company achieved massive market penetration in the retail and wellness sectors.

The company went public on the Tokyo Stock Exchange (TYO) in 2013. His structural contribution is tied to building a successful retail model focused on essential goods. The family maintains control, with his son Yukitaka overseeing product development.

Advertisement

Masateru Uno & family's Timeline


1997:

Founds Cosmos Pharmaceutical.

2013:

Cosmos Pharmaceutical executes its IPO.

Ongoing:

Continues as Chairman, guiding the retail chain.

Major Business Ventures and Investments


Masateru Uno's wealth is concentrated in his family's controlling stake in the publicly traded retail giant, Cosmos Pharmaceutical.

  • Cosmos Pharmaceutical (TYO: 3349): Founder and Chairman of the drugstore chain.
  • Products: Sells medicines, cosmetics, food, and beverages.
  • Family Role: His son, Yukitaka, is a director and heads product development.

Advertisement

Philanthropy and Social Impact


Fashion, Style, and Lifestyle


Advertisement

Quotes and Philosophy


No publicly available quotes.

Fun Facts & Trivia


  • He is the Founder and Chairman of Cosmos Pharmaceutical, which operates over 1,500 drugstores in Japan.
  • The company sells medicines, cosmetics, food, and beverages.
  • His son, Yukitaka, is a director and heads product development.

Advertisement

More Profiles


Alberto Coppel Luken

+0.56% | +$10.02M

Naresh Jain

-0.34% | -$4.97M

You May Like


Sources & References


This profile is compiled from verified biographical and financial records:

  • Wealth Data: Real-time tracking and historical data from Forbes Billionaires and the Bloomberg Billionaires Index.
  • Biographical Records: Educational and career history sourced from Reuters, The Wall Street Journal, and official university alumni directories.
  • Regulatory Filings: Shareholder and executive disclosures from stock exchange databases, including HKEX, SSE, SZSE, and SEC EDGAR.
  • Corporate History: Primary data from annual company reports, founding charters, and verified press announcements.

All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.

If you find any inaccuracies, please report them to admin@redcarpetlife.in

Sponsored Content